Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Share-based Compensation (2020 - 2025)

Celularity has reported Share-based Compensation over the past 6 years, most recently at $471000.0 for Q3 2025.

  • Quarterly results put Share-based Compensation at $471000.0 for Q3 2025, down 82.37% from a year ago — trailing twelve months through Sep 2025 was $6.2 million (down 49.55% YoY), and the annual figure for FY2024 was $11.6 million, down 22.96%.
  • Share-based Compensation for Q3 2025 was $471000.0 at Celularity, up from $108000.0 in the prior quarter.
  • Over the last five years, Share-based Compensation for CELU hit a ceiling of $28.2 million in Q2 2021 and a floor of $108000.0 in Q2 2025.
  • Median Share-based Compensation over the past 5 years was $3.0 million (2024), compared with a mean of $4.6 million.
  • Biggest five-year swings in Share-based Compensation: soared 140.04% in 2022 and later tumbled 96.39% in 2025.
  • Celularity's Share-based Compensation stood at $1.9 million in 2021, then surged by 126.9% to $4.4 million in 2022, then decreased by 18.49% to $3.6 million in 2023, then dropped by 17.73% to $2.9 million in 2024, then tumbled by 83.99% to $471000.0 in 2025.
  • The last three reported values for Share-based Compensation were $471000.0 (Q3 2025), $108000.0 (Q2 2025), and $2.6 million (Q1 2025) per Business Quant data.